AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P GOBAR L HOHENSTEIN M AUGUSTINE S GOLDENBERG D TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 7-7
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P GOBAR L HOHENSTEIN M AUGUSTINE S GOLDENBERG D TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 45-45
ANAPLASTIC LYMPHOMA KINASE (ALK) - AN IMPORTANT PREDICTOR OF SURVIVALIN PERIPHERAL T-CELL LYMPHOMA
Authors: AOUN P GREINER T VOSE J GORDON B KOLLATH J MORRIS S CHAN W WEISENBURGER D
Citation: P. Aoun et al., ANAPLASTIC LYMPHOMA KINASE (ALK) - AN IMPORTANT PREDICTOR OF SURVIVALIN PERIPHERAL T-CELL LYMPHOMA, Modern pathology, 11(1), 1998, pp. 125-125
THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR AND COMBINED CULTURE-MOLECULAR METHODS
Authors: WU GQ SHARP JG WU G VOSE J GREINER TC CHAN WC
Citation: Gq. Wu et al., THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR AND COMBINED CULTURE-MOLECULAR METHODS, Modern pathology, 11(1), 1998, pp. 142-142
2-CHLORODEOXYADENOSINE AS INITIAL THERAPY FOR ADVANCED LOW-GRADE LYMPHOMAS
Authors: CANFIELD VA VOSE J GUINEY P BENNETT B NICHOLS C
Citation: Va. Canfield et al., 2-CHLORODEOXYADENOSINE AS INITIAL THERAPY FOR ADVANCED LOW-GRADE LYMPHOMAS, Leukemia & lymphoma, 24(3-4), 1997, pp. 335-339
I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) - RESULTS OF A REPETITIVE DOSING TRIAL, The Journal of nuclear medicine, 38(5), 1997, pp. 211-211
THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR AND COMBINED CULTURE-MOLECULAR METHODS
Authors: WU GQ SHARP JG VOSE J GREINER TC CHAN WC
Citation: Gq. Wu et al., THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR AND COMBINED CULTURE-MOLECULAR METHODS, British Journal of Haematology, 99(4), 1997, pp. 873-881
OUTCOMES OF PATIENTS WITH BONE-MARROW METASTASES TREATED WITH HIGH-DOSE THERAPY AND RESCUED WITH PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: KESSINGER A ANDERSON J BIERMAN P BISHOP M REED E TARANTOLO S VOSE J ARMITAGE J
Citation: A. Kessinger et al., OUTCOMES OF PATIENTS WITH BONE-MARROW METASTASES TREATED WITH HIGH-DOSE THERAPY AND RESCUED WITH PERIPHERAL-BLOOD PROGENITOR CELLS, Blood, 90(10), 1997, pp. 1022-1022
LONG-TERM OUTCOME OF AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR CHRONICLYMPHOCYTIC-LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA (B-CLL)
Authors: PAVLETIC Z BIERMAN P VOSE J BISHOP M WU D PIERSON J KOLLATH J KESSINGER A ARMITAGE J
Citation: Z. Pavletic et al., LONG-TERM OUTCOME OF AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR CHRONICLYMPHOCYTIC-LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA (B-CLL), Blood, 90(10), 1997, pp. 1032-1032
SAFETY AND ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS (PTS) WITH DELAYED PLATELET RECOVERY (DPR)
Authors: NASH R KURZROCK R DIPERSIO J NIMER S VOSE J MAHARAJ D LINKER C NADEMANEE A NEGRIN R ASHBY M TREMBLAY T JONES D APPELBAUM F CHAMPLIN R
Citation: R. Nash et al., SAFETY AND ACTIVITY OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS (PTS) WITH DELAYED PLATELET RECOVERY (DPR), Blood, 90(10), 1997, pp. 1151-1151
A MULTICENTER PHASE-II STUDY OF I-131 ANTI-B1 ANTIBODY (BEXXAR) IN PATIENTS (PTS) WITH CHEMOTHERAPY-RELAPSED REFRACTORY LOW-GRADE OR TRANSFORMED LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMA (NHL)/
Authors: KAMINSKI MS VOSE J SALEH M LISTER A KNOX S CROWTHER D ZELENETZ AD COLCHER D WAHL R
Citation: Ms. Kaminski et al., A MULTICENTER PHASE-II STUDY OF I-131 ANTI-B1 ANTIBODY (BEXXAR) IN PATIENTS (PTS) WITH CHEMOTHERAPY-RELAPSED REFRACTORY LOW-GRADE OR TRANSFORMED LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMA (NHL)/, Blood, 90(10), 1997, pp. 2268-2268
X-INACTIVATION PATTERNS IN ABMT PATIENTS - EVIDENCE FOR CLONAL EVOLUTION
Authors: PROVOST S MATTIOLI J GUERTIN MJ VOSE J BUSQUE L
Citation: S. Provost et al., X-INACTIVATION PATTERNS IN ABMT PATIENTS - EVIDENCE FOR CLONAL EVOLUTION, Blood, 88(10), 1996, pp. 441-441
EFFECT OF FOLLICULARITY ON OUTCOME OF HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) FOR LARGE-CELL NON-HODGKINS-LYMPHOMA
Authors: VOSE J LYNCH J BIERMAN P ANDERSON J KESSINGER A ARMITAGE JO
Citation: J. Vose et al., EFFECT OF FOLLICULARITY ON OUTCOME OF HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) FOR LARGE-CELL NON-HODGKINS-LYMPHOMA, Blood, 88(10), 1996, pp. 476-476
THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL
Authors: VOSE J COLCHER D BIERMAN P LEICHNER P AKABANI G HARRISON K HOHENSTEIN M LESSER S HAMMERSHAIMB L GOLDENBERG DM TEMPERO M ARMITAGE J
Citation: J. Vose et al., THERAPY OF REFRACTORY NON-HODGKINS-LYMPHOMA (NHL) WITH I-131 LL2 (ANTI-CD22) RADIOIMMUNOTHERAPY (RIT) - RESULTS OF A REPETITIVE DOSING TRIAL, Blood, 88(10), 1996, pp. 2258-2258
PHASE I II STUDY INCORPORATING INTRAVENOUS HYDROXYUREA INTO HIGH-DOSECHEMOTHERAPY FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED AND REFRACTORY INTERMEDIATE-GRADE AND HIGH-GRADE MALIGNANT-LYMPHOMA/
Authors: VAUGHAN WP KRIS E VOSE J BIERMAN PJ GWILT P ARMITAGE JO
Citation: Wp. Vaughan et al., PHASE I II STUDY INCORPORATING INTRAVENOUS HYDROXYUREA INTO HIGH-DOSECHEMOTHERAPY FOR PATIENTS WITH PRIMARY REFRACTORY OR RELAPSED AND REFRACTORY INTERMEDIATE-GRADE AND HIGH-GRADE MALIGNANT-LYMPHOMA/, Journal of clinical oncology, 13(5), 1995, pp. 1089-1095
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA
Authors: VANBESIEN K ROWLINGS PA SOBOCINSKI KA PHILLIPS G VOSE J MCCARTHY P KLEIN JP CHAMPLIN R HOROWITZ MM
Citation: K. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA, Experimental hematology, 23(8), 1995, pp. 860-860
LYMPHOMA PATIENTS WHO REQUIRE PLATELET TRANSFUSIONS DURING BLOOD STEM-CELL COLLECTION HAVE SLOWER PLATELET RECOVERY AFTER HIGH-DOSE THERAPYAND AUTOTRANSPLANT
Authors: KESSINGER A ANDERSON J BISHOP M VOSE J BIERMAN P ARMITAGE JO
Citation: A. Kessinger et al., LYMPHOMA PATIENTS WHO REQUIRE PLATELET TRANSFUSIONS DURING BLOOD STEM-CELL COLLECTION HAVE SLOWER PLATELET RECOVERY AFTER HIGH-DOSE THERAPYAND AUTOTRANSPLANT, Blood, 86(10), 1995, pp. 397-397
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA
Authors: VANBESIEN K ROWLINGS PA SOBOCINSKI KA PHILLIPS G VOSE J MCCARTHY P KLEIN JP CHAMPLIN R HOROWITZ MM
Citation: K. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LOW-GRADE LYMPHOMA, Blood, 86(10), 1995, pp. 824-824
COMPARISON OF THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR, CULTUREAND COMBINED CULTURE-MOLECULAR METHODS
Authors: WU G SHARP JG WU G VOSE J GREINER TC CHAN WC
Citation: G. Wu et al., COMPARISON OF THE DETECTION OF MINIMAL LYMPHOMA BY MOLECULAR, CULTUREAND COMBINED CULTURE-MOLECULAR METHODS, Blood, 86(10), 1995, pp. 2124-2124
STROMA MAINTAINS THE SURVIVAL OF B-LYMPHOMA-CELLS BY INHIBITING APOPTOSIS
Authors: WEEKES CD LANG M PIRRUCELLO S VOSE J SHARP JG
Citation: Cd. Weekes et al., STROMA MAINTAINS THE SURVIVAL OF B-LYMPHOMA-CELLS BY INHIBITING APOPTOSIS, Blood, 86(10), 1995, pp. 3292-3292
CLINICAL OUTCOME OF PERIPHERAL-BLOOD STEM-CELL SUPPORT
Authors: KESSINGER A ARMITAGE J BIERMAN P BISHOP M JOSHI S REED E SHARP G TALMADGE J VOSE J
Citation: A. Kessinger et al., CLINICAL OUTCOME OF PERIPHERAL-BLOOD STEM-CELL SUPPORT, Medical oncology, 11(2), 1994, pp. 43-46
ANALYSIS OF PREDICTORS FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) MOBILIZED PERIPHERAL STEM-CELL YIELD
Authors: WATANABE T BISHOP MR ANDERSON J PETERSEN K JACKSON J VOSE J BIERMAN P ARMITAGE J REED E TARANTOLO S KESSINGER A
Citation: T. Watanabe et al., ANALYSIS OF PREDICTORS FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) MOBILIZED PERIPHERAL STEM-CELL YIELD, Experimental hematology, 22(8), 1994, pp. 781-781
SOIL PCO(2), SOIL RESPIRATION, AND ROOT ACTIVITY IN CO2-FUMIGATED ANDNITROGEN-FERTILIZED PONDEROSA PINE
Authors: JOHNSON D GEISINGER D WALKER R NEWMAN J VOSE J ELLIOT K BALL T
Citation: D. Johnson et al., SOIL PCO(2), SOIL RESPIRATION, AND ROOT ACTIVITY IN CO2-FUMIGATED ANDNITROGEN-FERTILIZED PONDEROSA PINE, Plant and soil, 165(1), 1994, pp. 129-138
PLANT-PRODUCTION AND SOIL-MICROORGANISMS IN LATE-SUCCESSIONAL ECOSYSTEMS - A CONTINENTAL-SCALE STUDY
Authors: ZAK DR TILMAN D PARMENTER RR RICE CW FISHER FM VOSE J MILCHUNAS D MARTIN CW
Citation: Dr. Zak et al., PLANT-PRODUCTION AND SOIL-MICROORGANISMS IN LATE-SUCCESSIONAL ECOSYSTEMS - A CONTINENTAL-SCALE STUDY, Ecology, 75(8), 1994, pp. 2333-2347
MYELODYSPLASTIC SYNDROME AFTER AUTOLOGOUS TRANSPLANT FOR LYMPHOMA
Authors: ANDERSON JR VOSE J KESSINGER A
Citation: Jr. Anderson et al., MYELODYSPLASTIC SYNDROME AFTER AUTOLOGOUS TRANSPLANT FOR LYMPHOMA, Blood, 84(11), 1994, pp. 3988-3988
Risultati: 1-25 | 26-39